- Home
- LPSN vs ANEB Comparison
LPSN vs ANEB Comparison
Compare LPSN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- ANEB
- Stock Information
- Founded
- LPSN 1995
- ANEB 2020
- Country
- LPSN United States
- ANEB United States
- Employees
- LPSN N/A
- ANEB N/A
- Industry
- LPSN EDP Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- ANEB Health Care
- Exchange
- LPSN Nasdaq
- ANEB Nasdaq
- Market Cap
- LPSN 84.5M
- ANEB 98.6M
- IPO Year
- LPSN 2000
- ANEB 2021
- Fundamental
- Price
- LPSN $0.54
- ANEB $2.30
- Analyst Decision
- LPSN Hold
- ANEB Buy
- Analyst Count
- LPSN 1
- ANEB 2
- Target Price
- LPSN N/A
- ANEB $8.00
- AVG Volume (30 Days)
- LPSN 5.8M
- ANEB 104.8K
- Earning Date
- LPSN 11-06-2025
- ANEB 11-12-2025
- Dividend Yield
- LPSN N/A
- ANEB N/A
- EPS Growth
- LPSN N/A
- ANEB N/A
- EPS
- LPSN N/A
- ANEB N/A
- Revenue
- LPSN $271,750,000.00
- ANEB N/A
- Revenue This Year
- LPSN N/A
- ANEB N/A
- Revenue Next Year
- LPSN N/A
- ANEB N/A
- P/E Ratio
- LPSN N/A
- ANEB N/A
- Revenue Growth
- LPSN N/A
- ANEB N/A
- 52 Week Low
- LPSN $0.50
- ANEB $0.80
- 52 Week High
- LPSN $2.08
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- LPSN 31.20
- ANEB 49.32
- Support Level
- LPSN $0.52
- ANEB $2.23
- Resistance Level
- LPSN $0.60
- ANEB $2.47
- Average True Range (ATR)
- LPSN 0.05
- ANEB 0.10
- MACD
- LPSN -0.00
- ANEB -0.01
- Stochastic Oscillator
- LPSN 16.38
- ANEB 43.23
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies.